Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015

Lupus

Volumn 25, Issue 8, 2016, Pages 797-804

  Chan, E K L ^a   Damoiseaux, J ^b   De Melo Cruvinel, W ^c   Carballo, O G ^d   Conrad, K ^e   Francescantonio, P L C ^c   Fritzler, M J ^f   Garcia De La Torre, I ^g   Herold, M ^h   Mimori, T ⁱ   Satoh, M ^j   Von Muhlen C A ^k   Andrade, L E C ^l,m  

^a UNIVERSITY OF FLORIDA   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

^d Instituto Universitario Del Hospital Italiano ^*  (Argentina)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF GUADALAJARA   (Mexico)

^h INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁱ KYOTO UNIVERSITY   (Japan)

^j UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^k Brazilian Society of Dermatology   (Brazil)

^l FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^m Fleury   (Brazil)

more..

Author keywords

Antinuclear antibodies; autoantibodies; autoimmunity; consensus; standardization

Indexed keywords

ANTINUCLEAR ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BRAZIL; CLASSIFICATION; COMMUNITY; CONSENSUS; GERMANY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH PROMOTION; HEP 2 CELL LINE; HOSPITAL PATIENT; HUMAN; INTERNATIONAL COOPERATION; MEDICAL EXPERT; MEDICAL INFORMATICS; MEDICAL INFORMATION; PATIENT CARE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; RHEUMATIC DISEASE; SEARCH ENGINE; STANDARDIZATION; SYSTEMIC SCLEROSIS; WORKSHOP; AUTOIMMUNE DISEASES; BLOOD; CONSENSUS DEVELOPMENT; MASS SCREENING; PRACTICE GUIDELINE; STANDARDS;

ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; GERMANY; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC;

EID: 84973338576     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316640920     Document Type: Article

References (35)

1. Tan EM,. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-151.
2. Satoh M, Chan EKL, Sobel ES, et al. Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Exp Rev Clin Immunol 2007; 3: 721-738.
3. Meroni PL, Schur PH,. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010; 69: 1420-1422.
4. Agmon-Levin N, Damoiseaux J, Kallenberg C, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014; 73: 17-23.
5. Chan EKL, Damoiseaux J, Carballo OG, et al. Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015. Front Immunol 2015; 6: 412-412.
6. Chan EKL, de Melo Cruvinel W, Andrade LEC, The international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns (ICAP) initiative-Current state and perspectives. In: Conrad K, Chan EKL, Andrade LEC, Steiner G, Pruijn GJM, Shoenfeld Y, (eds). 12th Dresden Symposium on Autoantibodies, Dresden, Germany: Pabst Science Publishers, 2015, pp. 282-288.
7. Chan EKL, Fritzler MJ, Wiik A, et al. Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007; 6: 577-580.
8. Mahler M, Meroni PL, Andrade LE, et al. Towards a better understanding of the clinical association of anti-DFS70 autoantibodies. Autoimmun Rev 2016; 15: 198-201.
9. Ochs RL, Mahler M, Basu A, et al. The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med 2015. Epub ahead of print, DOI: 10.1007/s10238-015-0367-0.
10. Stinton LM, Eystathioy T, Selak S, Chan EKL, Fritzler MJ,. Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin Immunol 2004; 110: 30-44.
11. Nozawa K, Fritzler MJ, Chan EKL,. Unique and shared features of Golgi complex autoantigens. Autoimmun Rev 2005; 4: 35-41.
12. Nozawa K, Casiano CA, Hamel JC, Molinaro C, Fritzler MJ, Chan EKL,. Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis. Arthritis Res 2002; 4: R3-R3.
13. Keppeke GD, Nunes E, Ferraz ML, et al. Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-alpha. PLoS One 2012; 7: e45392-e45392.
14. Covini G, Carcamo WC, Bredi E, von Muhlen CA, Colombo M, Chan EKL,. Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Antivir Ther 2012; 17: 805-811.
15. Carcamo WC, Ceribelli A, Calise SJ, et al. Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients. J Clin Immunol 2013; 33: 420-426.
16. Carcamo WC, Calise SJ, von Muhlen CA, Satoh M, Chan EKL,. Molecular cell biology and immunobiology of mammalian rod/ring structures. Int Rev Cell Mol Biol 2014; 308: 35-74.
17. Andrade LEC, Chan EKL, Peebles CL, Tan EM,. Two major autoantigen-antibody systems of the mitotic spindle apparatus. Arthritis Rheum 1996; 39: 1643-1653.
18. Mahler M, Fritzler MJ, Satoh M,. Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen. Autoimmun Rev 2015; 14: 254-257.
19. Kayser C, Fritzler MJ,. Autoantibodies in systemic sclerosis: unanswered questions. Front Immunol 2015; 6: 167-167.
20. Damoiseaux J, Agmon-Levin N, Van Blerk M, et al. From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries. Clin Exp Rheumatol 2014; 32: 539-546.
21. Damoiseaux JG, Tervaert JW,. From ANA to ENA: how to proceed? Autoimmun Rev 2006; 5: 10-17.
22. Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EKL,. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 2015. Epub ahead of print, DOI: 10.1007/s12016-015-8510-y.
23. Mahler M, Dervieux T,. Comments on recent advances and recommendations for the assessment of autoantibodies to cellular antigens referred as antinuclear antibodies. Ann Rheum Dis 2014; 73: e36-e36.
24. Mahler M, Meroni PL, Bossuyt X, Fritzler MJ,. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014; 2014: 315179-315179.
25. Dellavance A, Alvarenga RR, Rodrigues SH, et al. Autoantibodies to 60kDa SS-A/Ro yield a specific nuclear myriad discrete fine speckled immunofluorescence pattern. J Immunol Methods 2013; 390: 35-40.
26. Covini G, Chan EKL, Nishioka M, Morshed SA, Reed SI, Tan EM,. Immune response to cyclin B1 in hepatocellular carcinoma. Hepatology 1997; 25: 75-80.
27. Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EKL,. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol 2007; 46: 107-114.
28. Muro Y, Chan EKL, Landberg G, Tan EM,. A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells. Biochem Biophys Res Commun 1995; 207: 1029-1037.
29. Furuta K, Chan EKL, Kiyosawa K, Reimer G, Luderschmidt C, Tan EM,. Heterochromatin protein HP1Hsbeta (p25beta) and its localization with centromeres in mitosis. Chromosoma 1997; 106: 11-19.
30. Fritzler MJ, Kerfoot SM, Feasby TE, et al. Autoantibodies from patients with idiopathic ataxia bind to M-phase phosphoprotein-1 (MPP1). J Investig Med 2000; 48: 28-39.
31. von Muhlen CA, Chan EKL, Peebles CL, Imai H, Kiyosawa K, Tan EM,. Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases. Clin Exp Immunol 1995; 100: 67-74.
32. Soo Hoo L, Zhang JY, Chan EKL,. Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene 2002; 21: 5006-5015.
33. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
34. Damoiseaux J, von Muhlen CA, Garcia-De La Torre I, et al. International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Autoimmun Highlights 2016; 7: 1-1.
35. Shoenfeld Y, Cervera R, Haass M, et al. EASI-The European Autoimmunity Standardisation Initiative: a new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe. Ann N Y Acad Sci 2007; 1109: 138-144.